424 related articles for article (PubMed ID: 20574037)
1. Redefining dysferlinopathy phenotypes based on clinical findings and muscle imaging studies.
Paradas C; Llauger J; Diaz-Manera J; Rojas-García R; De Luna N; Iturriaga C; Márquez C; Usón M; Hankiewicz K; Gallardo E; Illa I
Neurology; 2010 Jul; 75(4):316-23. PubMed ID: 20574037
[TBL] [Abstract][Full Text] [Related]
2. Pattern of skeletal muscle involvement in primary dysferlinopathies: a whole-body 3.0-T magnetic resonance imaging study.
Kesper K; Kornblum C; Reimann J; Lutterbey G; Schröder R; Wattjes MP
Acta Neurol Scand; 2009 Aug; 120(2):111-8. PubMed ID: 19154541
[TBL] [Abstract][Full Text] [Related]
3. Painful enlargement of the calf muscles in limb girdle muscular dystrophy type 2B (LGMD2B) with a novel compound heterozygous mutation in DYSF.
Diers A; Carl M; Stoltenburg-Didinger G; Vorgerd M; Spuler S
Neuromuscul Disord; 2007 Feb; 17(2):157-62. PubMed ID: 17129727
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic study in 40 patients with dysferlin gene mutations: high frequency of atypical phenotypes.
Nguyen K; Bassez G; Krahn M; Bernard R; Laforêt P; Labelle V; Urtizberea JA; Figarella-Branger D; Romero N; Attarian S; Leturcq F; Pouget J; Lévy N; Eymard B
Arch Neurol; 2007 Aug; 64(8):1176-82. PubMed ID: 17698709
[TBL] [Abstract][Full Text] [Related]
5. Dysferlin mutations in LGMD2B, Miyoshi myopathy, and atypical dysferlinopathies.
Nguyen K; Bassez G; Bernard R; Krahn M; Labelle V; Figarella-Branger D; Pouget J; Hammouda el H; Béroud C; Urtizberea A; Eymard B; Leturcq F; Lévy N
Hum Mutat; 2005 Aug; 26(2):165. PubMed ID: 16010686
[TBL] [Abstract][Full Text] [Related]
6. Novel DYSF mutations in Thai patients with distal myopathy.
Liewluck T; Pongpakdee S; Witoonpanich R; Sangruchi T; Pho-Iam T; Limwongse C; Thongnoppakhun W; Boonyapisit K; Sopassathit V; Phudhichareonrat S; Suthiponpaisan U; Raksadawan N; Goto K; Hayashi YK; Nishino I
Clin Neurol Neurosurg; 2009 Sep; 111(7):613-8. PubMed ID: 19493611
[TBL] [Abstract][Full Text] [Related]
7. Dysferlinopathy: a clinical and histopathological study of 28 patients from India.
Nalini A; Gayathri N
Neurol India; 2008; 56(3):379-85; discussion 386-7. PubMed ID: 18974568
[TBL] [Abstract][Full Text] [Related]
8. Symptomatic dysferlin gene mutation carriers: characterization of two cases.
Illa I; De Luna N; Domínguez-Perles R; Rojas-García R; Paradas C; Palmer J; Márquez C; Gallano P; Gallardo E
Neurology; 2007 Apr; 68(16):1284-9. PubMed ID: 17287450
[TBL] [Abstract][Full Text] [Related]
9. Mutation finding in patients with dysferlin deficiency and role of the dysferlin interacting proteins annexin A1 and A2 in muscular dystrophies.
Cagliani R; Magri F; Toscano A; Merlini L; Fortunato F; Lamperti C; Rodolico C; Prelle A; Sironi M; Aguennouz M; Ciscato P; Uncini A; Moggio M; Bresolin N; Comi GP
Hum Mutat; 2005 Sep; 26(3):283. PubMed ID: 16100712
[TBL] [Abstract][Full Text] [Related]
10. Comparing clinical data and muscle imaging of DYSF and ANO5 related muscular dystrophies.
Ten Dam L; van der Kooi AJ; Rövekamp F; Linssen WH; de Visser M
Neuromuscul Disord; 2014 Dec; 24(12):1097-102. PubMed ID: 25176504
[TBL] [Abstract][Full Text] [Related]
11. Clinical features and a mutation with late onset of limb girdle muscular dystrophy 2B.
Takahashi T; Aoki M; Suzuki N; Tateyama M; Yaginuma C; Sato H; Hayasaka M; Sugawara H; Ito M; Abe-Kondo E; Shimakura N; Ibi T; Kuru S; Wakayama T; Sobue G; Fujii N; Saito T; Matsumura T; Funakawa I; Mukai E; Kawanami T; Morita M; Yamazaki M; Hasegawa T; Shimizu J; Tsuji S; Kuzuhara S; Tanaka H; Yoshioka M; Konno H; Onodera H; Itoyama Y
J Neurol Neurosurg Psychiatry; 2013 Apr; 84(4):433-40. PubMed ID: 23243261
[TBL] [Abstract][Full Text] [Related]
12. A case of dysferlinopathy presenting choreic movements.
Takahashi T; Aoki M; Imai T; Yoshioka M; Konno H; Higano S; Onodera Y; Saito H; Kimura I; Itoyama Y
Mov Disord; 2006 Sep; 21(9):1513-5. PubMed ID: 16817213
[TBL] [Abstract][Full Text] [Related]
13. Private dysferlin exon skipping mutation (c.5492G>A) with a founder effect reveals further alternative splicing involving exons 49-51.
Santos R; Oliveira J; Vieira E; Coelho T; Carneiro AL; Evangelista T; Dias C; Fortuna A; Geraldo A; Negrão L; Guimarães A; Bronze-da-Rocha E
J Hum Genet; 2010 Aug; 55(8):546-9. PubMed ID: 20535123
[TBL] [Abstract][Full Text] [Related]
14. DYSF mutation analysis in a group of Chinese patients with dysferlinopathy.
Zhao Z; Hu J; Sakiyama Y; Okamoto Y; Higuchi I; Li N; Shen H; Takashima H
Clin Neurol Neurosurg; 2013 Aug; 115(8):1234-7. PubMed ID: 23254335
[TBL] [Abstract][Full Text] [Related]
15. Dysferlin aggregation in limb-girdle muscular dystrophy type 2B/Miyoshi Myopathy necessitates mutational screen for diagnosis [corrected].
Nilsson MI; Laureano ML; Saeed M; Tarnopolsky MA
Muscle Nerve; 2013 May; 47(5):740-7. PubMed ID: 23519732
[TBL] [Abstract][Full Text] [Related]
16. Late onset in dysferlinopathy widens the clinical spectrum.
Klinge L; Dean AF; Kress W; Dixon P; Charlton R; Müller JS; Anderson LV; Straub V; Barresi R; Lochmüller H; Bushby K
Neuromuscul Disord; 2008 Apr; 18(4):288-90. PubMed ID: 18396043
[TBL] [Abstract][Full Text] [Related]
17. Limb girdle muscular dystrophy type 2A in India: a study based on semi-quantitative protein analysis, with clinical and histopathological correlation.
Pathak P; Sharma MC; Sarkar C; Jha P; Suri V; Mohd H; Singh S; Bhatia R; Gulati S
Neurol India; 2010; 58(4):549-54. PubMed ID: 20739790
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the DYSF mutational spectrum in a large cohort of patients.
Krahn M; Béroud C; Labelle V; Nguyen K; Bernard R; Bassez G; Figarella-Branger D; Fernandez C; Bouvenot J; Richard I; Ollagnon-Roman E; Bevilacqua JA; Salvo E; Attarian S; Chapon F; Pellissier JF; Pouget J; Hammouda el H; Laforêt P; Urtizberea JA; Eymard B; Leturcq F; Lévy N
Hum Mutat; 2009 Feb; 30(2):E345-75. PubMed ID: 18853459
[TBL] [Abstract][Full Text] [Related]
19. Identification of a novel founder mutation in the DYSF gene causing clinical variability in the Spanish population.
Vilchez JJ; Gallano P; Gallardo E; Lasa A; Rojas-García R; Freixas A; De Luna N; Calafell F; Sevilla T; Mayordomo F; Baiget M; Illa I
Arch Neurol; 2005 Aug; 62(8):1256-9. PubMed ID: 16087766
[TBL] [Abstract][Full Text] [Related]
20. Variable reduction of caveolin-3 in patients with LGMD2B/MM.
Walter MC; Braun C; Vorgerd M; Poppe M; Thirion C; Schmidt C; Schreiber H; Knirsch UI; Brummer D; Müller-Felber W; Pongratz D; Müller-Höcker J; Huebner A; Lochmüller H
J Neurol; 2003 Dec; 250(12):1431-8. PubMed ID: 14673575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
